Dr. Ali Tinazli Joins Fluxergy as Chief Commercial Officer

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Fluxergy, developer of innovative “point-of-care” medical diagnostics systems, announced today that Dr. Ali Tinazli has joined its executive team as Chief Commercial Officer. Dr. Tinazli will oversee all commercial operations, strategic planning, business development, sales, and strategic partnerships for the point-of-care (POC) diagnostics company.

Fluxergy is principally funded by technology entrepreneur and philanthropist John Tu, co-founder and CEO of Fountain Valley-based Kingston Technology, the world’s leader in memory modules and storage systems.

Before joining Fluxergy, Dr. Ali Tinazli led corporate-wide, global strategy for Healthcare and Life Sciences at Hewlett-Packard (HP Inc.).

“Fluxergy possesses an exciting and very promising technology platform and scalable manufacturing approach that has the potential to deliver highly innovative POC diagnostics systems for a wide range of potential applications in human and animal healthcare,” said Dr. Tinazli. “Our roadmap of product solutions seeks to make diagnostic testing more widely accessible and far more affordable with considerable disruptive potential, from farm to pharmacy. We also believe that consumerization and digitization of healthcare diagnostics will be indispensable, not only in providing very positive impacts on healthcare outcomes, but also in helping to address the healthcare cost crisis across economies globally.”

The company, backed by Kingston Technology co-founder John Tu, is developing a fully integrated sample-to-answer point-of-care system. The core of this system is a highly scalable microfluidic test card which allows for the combined detection of proteins, nucleic acids, small molecules, and cells. Fluxergy envisions a potentially wide range of deployment in the life sciences, environmental, food, and healthcare testing continuum. Primary applications are presently targeted in the areas of human and veterinary health.

The company expects to introduce its first product in veterinary health in 2020, focused on equine diagnostics, followed up by exploration of additional vertical segments, and later, in human studies.

“Today’s testing market does not reach every single patient because of cost and accessibility,” said Fluxergy’s President and Co-Founder Tej Patel. “Fluxergy’s vision is to make healthcare testing widely accessible, convenient, fast, and affordable – enabled by highly scalable consumable test cards and interconnected testing data management systems. Dr. Tinazli’s extensive and diverse experience within both the medical startup community and at industry leaders like HP and Sony make him an invaluable asset to our team and our growth strategy.”

Dr. Ali Tinazli received his Ph.D. in Biochemistry from J.W. Goethe University in Germany. After receiving his Ph.D., Dr. Tinazli worked in Corporate Development at Applied Biosystems (now: Thermo Fisher). At Sony, Dr. Tinazli built a healthcare consumables business which got acquired by Stratec.
The Fluxergy Analyzer and Test Card

Dr. Tinazli also currently serves as an angel investor and board member at various start-ups ranging from cybersecurity to oncology.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.